April 2023

Generics’ longevity hinges on steady, straightforward storytelling

The pharma industry must place more value on nontraditional and ‘skills-first’ pathway models

The pharma industry is running out of lab and manufacturing space — but there are options

How advanced therapy manufacturers can apply DX across facilities

With the fate of titanium dioxide uncertain, pharma companies should be looking for alternatives.